Johnstown, PA – (May 26, 2023) – Peniel Residential Drug/Alcohol Treatment Center is pleased to announce the generous grant of $15,000 awarded by Lee Initiatives (https://www.leeinitiatives.com/), a philanthropic organization based in Johnstown, PA. This significant funding will directly benefit Peniel’s Treatment Scholarship Program, enabling individuals in need to receive life-changing substance use treatment.
Lee Initiatives has a long-standing commitment to supporting organizations that address critical community needs, and their investment in Peniel reflects their dedication to improving the lives of individuals struggling with addiction. With this grant, Peniel will expand its capacity to provide comprehensive, evidence-based treatment services to individuals in our region. The funds will directly support the Treatment Scholarship Program, ensuring that financial barriers do not hinder access to the care and support needed for recovery.
“We are extremely grateful for the generous grant from Lee Initiatives,” said Durean Coleman, Public Relations Director at Peniel. “This funding will enable us to augment our scholarship program and extend our reach to those who may not have had the opportunity to receive treatment otherwise. We are honored to partner with Lee Initiatives in making a positive impact on the lives of individuals and families affected by addiction.”
This grant from Lee Initiatives will enable Peniel to support individuals in need on their journey to recovery. It exemplifies the power of collaboration between organizations committed to addressing the substance abuse crisis and bringing hope and healing to communities.
About Lee Initiatives
Lee Initiatives (https://www.leeinitiatives.com/) is a philanthropic organization based in Johnstown, PA, dedicated to supporting initiatives that enhance the quality of life in the community. By partnering with local organizations, Lee Initiatives strives to address critical needs and make a positive impact in areas such as healthcare, education, social services, and more.